Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain

Experimental Neurology

Volumn 161, Issue 1, 2000, Pages 392-396

  Yurek, David M ^a   Fletcher Turner, Anita ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

6 hydroxydopamine; Aging; Brown Norway Fischer 344 F1 hybrid rats; Dopamine; Neurotrophic factor; Nigrostriatal; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE SEVERITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; TISSUE DISTRIBUTION;

EID: 0034054501     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7274     Document Type: Article

References (14)

1. Carvey P. M., Vu T. Q., Ling Z. D., Lipton J. W., Sortwell C. E., Collier T. J. The compensatory increase in striatal trophic activity is reduced in the aged rat brain. Exp. Neurol. 135:1998;389.
2. Collier T. J., Steece-Collier K. 28-month-old rats with a 16-month history of unilateral nigrostriatal lesion: Drug-induced behavior and response to grafted dopamine neurons and Schwann cells. Soc. Neurosci. 22:1996;1209.
3. Collier T. J., Kordower J. H. Neural transplantation for the treatment of Parkinson's disease: Present-day optimism and future challenges. Jankovic J., Tolosa E. Parkinson's Disease and Movement Disorders. 1998;1065-1083 Williams & Wilkins, Baltimore.
4. Collier T. J., Sortwell C. E., Daley B. F. Diminished viability, growth and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion. An argument for neurotrophic supplementation. J. Neurosci. 19:1999;5563-5573.
5. Kaseloo P. A., Lis A., Asada H., Barone T. A., Plunkett R. J. In vitro assessment of neurotrophic activity from the striatum of aging rats. Neurosci. Lett. 218:1996;157-160.
6. Nawa N., Carnahan J., Gall C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur. J. Neurosci. 7:1995;1527-1535.
7. Sauer H., Fischer W., Nikkhah G., Wiegand S. J., Brundin P., Lindsay R. M., Björklund A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 626:1993;37-44.
8. Seroogy K. B., Gall C. M. Expression of neurotrophins by midbrain dopaminergic neurons. Exp. Neurol. 124:1993;119-128.
9. Seroogy K. B., Lundgren K. H., Tran T. M. D., Guthrie K. M., Isackson P. J., Gall C. M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342:1994;321-334.
10. Venero J. L., Beck K. D., Hefti F. 6-hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra. NeuroReport. 5:1994;429-432.
11. Yurek D. M., Lu W., Hipkens S. B., Wiegand S. J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:1996;105-118.
12. Yurek D. M., Hipkens S. B., Wiegand S. J., Altar C. A. Optimal effect of BDNF on the development of fetal ventral mesencephalic tissue transplants coincides with the developmental expression of BDNF within the striatum. J. Neurosci. 18:1998;6040-6047.
13. Yurek, D. M., and K. B. Seroogy. 1999. Neurotrophic factor protection of dopaminergic neurons. In Neurobiology of the NeurotrophinsI. Mocchetti, Ed., Sullburger & Graham, New York, in press.
14. Zhou J., Pliego-Rivero B., Bradford H. F., Stern G. M. The BDNF content of postnatal and adult rat brain: The effects of 6-hydroxydopamine lesions in adult brain. Dev. Brain Res. 97:1996;297-303.